Search
Nuvalent Inc
NUVLAdd to Watchlist
123.965USD
0.0000.00%
Close 07-14 16:00（ET）Quotes delayed by 15 min
9.81BMarket Cap
LossP/E TTM
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Deerfield Management Company, L.P.
23.45%
Fidelity Management & Research Company LLC
14.19%
Paradigm BioCapital Advisors LP
7.16%
BlackRock Institutional Trust Company, N.A.
5.04%
Vanguard Portfolio Management, LLC
3.40%
Other
46.76%
Shareholders
Shareholders
Proportion
Deerfield Management Company, L.P.
23.45%
Fidelity Management & Research Company LLC
14.19%
Paradigm BioCapital Advisors LP
7.16%
BlackRock Institutional Trust Company, N.A.
5.04%
Vanguard Portfolio Management, LLC
3.40%
Other
46.76%
Shareholder Types
Shareholders
Proportion
Investment Advisor
43.62%
Hedge Fund
38.79%
Investment Advisor/Hedge Fund
21.04%
Individual Investor
2.77%
Venture Capital
2.58%
Private Equity
2.26%
Research Firm
1.46%
Sovereign Wealth Fund
0.78%
Bank and Trust
0.33%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
490
86.91M
118.14%
+5.88M
2025Q4
462
75.27M
104.86%
-2.57M
2025Q3
440
73.50M
109.27%
-4.34M
2025Q2
438
75.09M
113.13%
-1.35M
2025Q1
443
75.23M
113.38%
-1.51M
2024Q4
428
73.56M
111.20%
-2.43M
2024Q3
401
72.99M
113.51%
-264.12K
2024Q2
367
68.27M
114.85%
-2.37M
2024Q1
344
66.52M
113.46%
-4.79M
2023Q4
296
66.77M
116.76%
+1.56M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Deerfield Management Company, L.P.
17.25M
23.57%
-742.57K
-4.13%
Dec 31, 2025
Fidelity Management & Research Company LLC
10.44M
14.27%
+685.62K
+7.03%
Dec 31, 2025
Paradigm BioCapital Advisors LP
5.27M
7.2%
--
--
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
3.71M
5.06%
+578.29K
+18.49%
Dec 31, 2025
Wellington Management Company, LLP
2.46M
3.36%
+160.96K
+7.00%
Dec 31, 2025
T. Rowe Price Associates, Inc.
2.10M
2.86%
+330.62K
+18.74%
Dec 31, 2025
JP Morgan Asset Management
2.01M
2.75%
+498.40K
+32.96%
Dec 31, 2025
RA Capital Management, LP
1.88M
2.57%
+633.60K
+50.83%
Dec 31, 2025
View more
Related ETFs
Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
Tema Oncology ETF
4.14%
ALPS Medical Breakthroughs ETF
2.65%
Global X Guru Index ETF
1.57%
State Street SPDR S&P Biotech ETF
1.16%
Virtus LifeSci Biotech Clinical Trials ETF
0.86%
iShares Health Innovation Active ETF
0.82%
Direxion Daily S&P Biotech Bull 3X Shares
0.72%
ProShares Ultra Nasdaq Biotechnology
0.65%
Invesco Nasdaq Biotechnology ETF
0.64%
iShares Biotechnology ETF
0.39%
View more
Tema Oncology ETF
Proportion4.14%
ALPS Medical Breakthroughs ETF
Proportion2.65%
Global X Guru Index ETF
Proportion1.57%
State Street SPDR S&P Biotech ETF
Proportion1.16%
Virtus LifeSci Biotech Clinical Trials ETF
Proportion0.86%
iShares Health Innovation Active ETF
Proportion0.82%
Direxion Daily S&P Biotech Bull 3X Shares
Proportion0.72%
ProShares Ultra Nasdaq Biotechnology
Proportion0.65%
Invesco Nasdaq Biotechnology ETF
Proportion0.64%
iShares Biotechnology ETF
Proportion0.39%